![]() Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601 |
Journal | Formal name:Anticancer Drugs |
Domestic / Foregin | Foregin |
Volume, Number, Page | 34(7),pp.857-65 |
Papers・Author | Ito Kimihiko., Nakagawa Mio., Shimokawa Mototsugu., Hori Kensuke., Tashima Lena., Goto Mayakoa., Yanagida Satoshi., Suzuki Jiro., Kaya Ryusuke., Kawabata Ayako., Yamada Kyosuke., Park Jongmyung., Nasu Hiroki., Nishio Shin., Kondo Eiji., Kaneda Michiko., Tsubamoto Hiroshi., Arakawa Atsushi., Nagasawa Takayuki., Motohashi Takashi |
Publication date | 2023/08 |